Avenue Therapeutics Inc (ATXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,923 | 6,429 | 3,912 | 663 | 605 |
| Operating Income | -3,923 | -6,429 | -3,912 | -663 | -605 |
| Other Income | -93 | -1,173 | 4,436 | 1 | 1 |
| Pre-tax Income | -4,016 | -7,602 | 524 | -662 | -604 |
| Net Income Continuous | -4,016 | -7,602 | 524 | -662 | -604 |
| Minority Interests | -9 | -66 | N/A | N/A | N/A |
| Net Income | $-4,007 | $-7,536 | $575 | $-662 | $-604 |
| EPS Basic Total Ops | -38.74 | -101.57 | 96.24 | -33.83 | -30.83 |
| EPS Basic Continuous Ops | -38.99 | -102.73 | 95.04 | -33.95 | -31.08 |
| EPS Diluted Total Ops | -38.74 | -101.57 | 96.24 | -33.83 | -30.83 |
| EPS Diluted Continuous Ops | -38.99 | -102.73 | 95.04 | -33.95 | -31.08 |
| EPS Diluted Before Non-Recurring Items | -39.10 | -103.01 | 92.48 | -33.84 | N/A |
| EBITDA(a) | $-3,923 | $-6,429 | $-3,912 | $-663 | $-605 |